Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Hui, San-ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S383000, C514S602000
Reexamination Certificate
active
07960416
ABSTRACT:
An emulsion composition comprising (1) a compound (I) represented by the formula (I) wherein each symbol is as defined in the specification (2) an anionic synthetic phospholipid in a proportion of about 0.0001 about 5% (W/V) relative to the composition in total, and (3) a naturally-occurring phospholipid in a proportion of about 0.1 about 10% (W/V) relative to the composition in total is provided.
REFERENCES:
patent: 5576016 (1996-11-01), Amselem et al.
patent: 5635491 (1997-06-01), Seki et al.
patent: 5814324 (1998-09-01), Sato et al.
patent: 6495604 (2002-12-01), Ichimori et al.
patent: 2003/0212114 (2003-11-01), Sato et al.
patent: WO99/46242 (1999-09-01), None
Supplementary European Search Report dated Aug. 31, 2009, in corresponding EP 01965853.3, 3 pages.
Washington, C., “Stability of lipid emulsions for drug delivery,” Advanced Drug Delivery Reviews, 1996, 20:131-145.
Nara Eiji
Sato Jun
Stevens Harold Jack
Taira Hikaru
Foley & Lardner LLP
Hui San-ming
Takeda Pharmaceutical Company Limited
LandOfFree
Stable emulsion composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable emulsion composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable emulsion composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2669024